🏢 官网IRELANCodex · 实盘不做把握 2/10
北京时间·🕒 发布 19:32:00(美东 07:32)·⟳ 抓取 19:33:26 +1m26s·⚡ 决策 07-31 19:34:36 +1m10s·88.1 天前
Elanco发布2025影响力报告,内容以ESG与业务进展回顾为主
本次为公司影响力/ESG报告发布,主要回顾创新、动物护理、可持续食品系统和社区投入,缺少可交易的新增订单、审批、业绩指引或资本配置变化。
📄 原文ELAN↗ 原文
Report highlights Elanco's impact through innovation, expanded access to animal care, a stronger and more sustainable f…
不做 Elanco Animal Health(ELAN.US)
影响力/ESG报告属于品牌宣传和年度回顾,缺少新增重大经营事实或短周期可交易边界,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-31 · 扩散 low · price-in 风险 medium ↗
关键理由
- 本次为公司影响力/ESG报告发布,主要回顾创新、动物护理、可持续食品系统和社区投入,缺少可交易的新增订单、审批、业绩指引或资本配置变化。
- 文中提到的2025创新收入、2031年前潜在审批和峰值销售额更像既有战略叙事汇总,不构成短周期可验证的增量催化。
主要风险
- 若后续公司单独披露具体产品审批、销售指引或重大订单,应作为新事件重新研判。
原文全文
展开原文 · 6,204 字
Report highlights Elanco's impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communities
INDIANAPOLIS
,
July 31, 2026
/PRNewswire/ --
Elanco Animal Health Incorporated
(NYSE: ELAN) today released its 2025 Impact Report, "Leading with Purpose," highlighting how the company brings together purpose, innovation and business strategy to help address some of society's most pressing challenges.
The report details Elanco's progress across four interconnected areas: going beyond for animals, customers, society and its people. Together, these priorities demonstrate how Elanco can help animals live healthier, more active lives; support farmers and veterinarians; strengthen the global food supply; and contribute to healthier, more resilient communities.
"Animals are at the center of two of society's most fundamental needs: nutritious food and meaningful companionship," said
Jeff Simmons
, president and CEO of Elanco. "As demand for both continues to grow, animal health has never been more important. Elanco and our industry help pets live longer, healthier lives while enabling farmers to produce safe, affordable and sustainable protein. By connecting our purpose with our strategy, we put impact at the heart of how we innovate and help address some of the world's most pressing challenges."
Report Highlights
Elanco's achievements highlighted in the report include:
Going Beyond for Animals
Generated
$892 million
in 2025 revenue from new innovation, led by products including Credelio Quattro, Zenrelia,
Experior
and AdTab.
Progressed Elanco's next wave of innovation, including 5-6 blockbuster-potential approvals by 2031, with unprobabilized potential peak sales value of more than
$2 billion
– effectively doubling the value of the last wave.
Established Credelio Quattro as Elanco's fastest pet health blockbuster and one of the fastest in the animal health industry.
Helped treat more than two million itchy dogs worldwide to date with Zenrelia.
Secured emergency and conditional regulatory authorizations to help protect pets and livestock from
New World
screwworm, an emerging pest that can infest any warm-blooded animals – including livestock and pets.
Supported more than 1,000 animal shelters and rescue organizations through Paws for Purpose+ and expanded partnerships with IndyHumane and Medical Mutts Service Dogs.
Going Beyond for Customers
Helped feedyards measure, quantify and monetize carbon-reduction interventions for more than 1.4 million cattle in 2025, resulting in more than 200,000 metric tons of CO₂e reductions.
Expanded the use of science-based products and digital tools, including Bovaer,
Experior
, Rumensin, Zimprova and UpLook, to help producers improve efficiency and environmental sustainability.
Continued investing in the wellbeing and development of veterinarians through mental health resources, professional education, fellowships and global academic partnerships.
Going Beyond for Society
Advanced food safety through a global Salmonella control program operating in 23 countries.
Promoted responsible antimicrobial use through industry-leading stewardship initiatives and global partnerships.
Launched Nutrition Secure Indy, providing animal protein, produce, milk and eggs to 250 Indianapolis families while studying the connection between nutrition access and health and community outcomes.
Opened Elanco's new global headquarters as the anchor of the
One Health Innovation District
, created in partnership with
Purdue University
to accelerate collaboration across animal, human and plant health.
Strengthened product and consumer safety by recovering more than 160,000 counterfeit products valued at over
$13 million
.
Going Beyond for Our People
Achieved an employee engagement score of 73%, 4 percentage points above the external benchmark.
Expanded employee ownership through a new ownership award program and strengthened an ownership mindset through Ascend.
Invested in leadership development through the launch of Leader 2030 and other programs focused on building the workforce of the future.
Mobilized employees to contribute more than 28,000 volunteer hours, with 22.6% employee participation, supporting 938 nonprofit organizations worldwide.
The report also outlines Elanco's governance and responsible business practices, including its approach to product quality and safety, animal welfare, environmental resilience, employee health and safety, ethical conduct and oversight of environmental, social and governance-related risks and opportunities.
"Our people bring our purpose to life every day, in laboratories, manufacturing sites, veterinary clinics, farms, communities and homes," Simmons said. "The progress reflected in this report demonstrates what is possible when innovation, customer value and purpose work together to improve the health of animals and the lives of the people who depend on them."
The complete 2025 Elanco Impact Report and supporting environmental, social and governance disclosures are
available here
.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at
www.elanco.com
.
Investor Contact: Tiffany Kanaga (765) 740-0314
tiffany.kanaga@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011
colleen.dekker@elancoah.com
View original content to download multimedia:
https://www.prnewswire.com/news-releases/elanco-releases-2025-impact-report-demonstrating-how-animal-health-helps-meet-societys-growing-needs-302839584.html
SOURCE Elanco Animal Health
INDIANAPOLIS
,
July 31, 2026
/PRNewswire/ --
Elanco Animal Health Incorporated
(NYSE: ELAN) today released its 2025 Impact Report, "Leading with Purpose," highlighting how the company brings together purpose, innovation and business strategy to help address some of society's most pressing challenges.
The report details Elanco's progress across four interconnected areas: going beyond for animals, customers, society and its people. Together, these priorities demonstrate how Elanco can help animals live healthier, more active lives; support farmers and veterinarians; strengthen the global food supply; and contribute to healthier, more resilient communities.
"Animals are at the center of two of society's most fundamental needs: nutritious food and meaningful companionship," said
Jeff Simmons
, president and CEO of Elanco. "As demand for both continues to grow, animal health has never been more important. Elanco and our industry help pets live longer, healthier lives while enabling farmers to produce safe, affordable and sustainable protein. By connecting our purpose with our strategy, we put impact at the heart of how we innovate and help address some of the world's most pressing challenges."
Report Highlights
Elanco's achievements highlighted in the report include:
Going Beyond for Animals
Generated
$892 million
in 2025 revenue from new innovation, led by products including Credelio Quattro, Zenrelia,
Experior
and AdTab.
Progressed Elanco's next wave of innovation, including 5-6 blockbuster-potential approvals by 2031, with unprobabilized potential peak sales value of more than
$2 billion
– effectively doubling the value of the last wave.
Established Credelio Quattro as Elanco's fastest pet health blockbuster and one of the fastest in the animal health industry.
Helped treat more than two million itchy dogs worldwide to date with Zenrelia.
Secured emergency and conditional regulatory authorizations to help protect pets and livestock from
New World
screwworm, an emerging pest that can infest any warm-blooded animals – including livestock and pets.
Supported more than 1,000 animal shelters and rescue organizations through Paws for Purpose+ and expanded partnerships with IndyHumane and Medical Mutts Service Dogs.
Going Beyond for Customers
Helped feedyards measure, quantify and monetize carbon-reduction interventions for more than 1.4 million cattle in 2025, resulting in more than 200,000 metric tons of CO₂e reductions.
Expanded the use of science-based products and digital tools, including Bovaer,
Experior
, Rumensin, Zimprova and UpLook, to help producers improve efficiency and environmental sustainability.
Continued investing in the wellbeing and development of veterinarians through mental health resources, professional education, fellowships and global academic partnerships.
Going Beyond for Society
Advanced food safety through a global Salmonella control program operating in 23 countries.
Promoted responsible antimicrobial use through industry-leading stewardship initiatives and global partnerships.
Launched Nutrition Secure Indy, providing animal protein, produce, milk and eggs to 250 Indianapolis families while studying the connection between nutrition access and health and community outcomes.
Opened Elanco's new global headquarters as the anchor of the
One Health Innovation District
, created in partnership with
Purdue University
to accelerate collaboration across animal, human and plant health.
Strengthened product and consumer safety by recovering more than 160,000 counterfeit products valued at over
$13 million
.
Going Beyond for Our People
Achieved an employee engagement score of 73%, 4 percentage points above the external benchmark.
Expanded employee ownership through a new ownership award program and strengthened an ownership mindset through Ascend.
Invested in leadership development through the launch of Leader 2030 and other programs focused on building the workforce of the future.
Mobilized employees to contribute more than 28,000 volunteer hours, with 22.6% employee participation, supporting 938 nonprofit organizations worldwide.
The report also outlines Elanco's governance and responsible business practices, including its approach to product quality and safety, animal welfare, environmental resilience, employee health and safety, ethical conduct and oversight of environmental, social and governance-related risks and opportunities.
"Our people bring our purpose to life every day, in laboratories, manufacturing sites, veterinary clinics, farms, communities and homes," Simmons said. "The progress reflected in this report demonstrates what is possible when innovation, customer value and purpose work together to improve the health of animals and the lives of the people who depend on them."
The complete 2025 Elanco Impact Report and supporting environmental, social and governance disclosures are
available here
.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at
www.elanco.com
.
Investor Contact: Tiffany Kanaga (765) 740-0314
tiffany.kanaga@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011
colleen.dekker@elancoah.com
View original content to download multimedia:
https://www.prnewswire.com/news-releases/elanco-releases-2025-impact-report-demonstrating-how-animal-health-helps-meet-societys-growing-needs-302839584.html
SOURCE Elanco Animal Health
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。